Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating

Amrize Ltd (NYSE:AMRZ) is among the 11 Newly-Listed NYSE Stocks to Buy Now. Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating On February 19, 2026, Oppenheimer increased its price target on Amrize Ltd (NYSE:AMRZ) to $70 from $64 and maintained an Outperform rating. The firm noted the shares moved higher after the company reported Q4 2025 EBITDA of $779M and issued 2026 revenue and profitability guidance that came in moderately above Street expectations. ...